• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec7
Molecular Partners AG Announces Positive Trial Results of MP0533 for AML at ASH Meeting
12:00
Nov12
Molecular Partners AG Submits IND Application for Small Cell Lung Cancer Drug
06:01
Nov3
Molecular Partners AG Releases Data on MP0533 Clinical Trial
06:00
Oct31
Molecular Partners released FY2025 Q3 earnings on October 30 (EST), actual EPS USD -0.3968 (forecast USD -0.4639)
03:00
Molecular Partners released FY2025 9 Months Earnings on October 30, 2025 (EST) with actual revenue of USD 0 and EPS of USD -1.5948
03:00
Oct30
Molecular Partners AG Reports Third Quarter Progress in Cancer Therapy and Appoints New Chief Science Officer
20:14

Schedules & Filings

Schedules
Filings
Oct30
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -14.84 M, EPS -0.3968

Aug25
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -25.5 M, EPS -0.682

May15
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -19.02 M, EPS -0.5158

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MGRT
13.050
+143.93%
+7.700
PCSA
6.680
+122.30%
+3.675
YCBD
2.270
+58.74%
+0.840
ATPC
0.1408
+56.44%
+0.051
VYNE
0.6000
+48.99%
+0.197
ANDG
23.500
+46.88%
+7.500
ISPO
4.170
+46.83%
+1.330
MDLN
41.000
+41.38%
+12.000
CGTL
1.250
+31.30%
+0.298
GLIBR
8.490
+29.03%
+1.910
View More